Cargando…

Airway Inflammatory/Immune Responses in COPD and Cystic Fibrosis

Detalles Bibliográficos
Autores principales:	De Rose, Virginia, Burgel, Pierre-Régis, Gaggar, Amit, Greene, Catherine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954891/ https://www.ncbi.nlm.nih.gov/pubmed/29853791 http://dx.doi.org/10.1155/2018/7280747

Ejemplares similares

Airway Epithelium Dysfunction in Cystic Fibrosis and COPD
por: De Rose, Virginia, et al.
Publicado: (2018)

Dysfunctional lung anatomy and small airways degeneration in COPD
por: Martin, Clémence, et al.
Publicado: (2013)

Mucus Plugs in Medium-sized Airways: A Novel Imaging Biomarker for Phenotyping Chronic Obstructive Pulmonary Disease
por: Chassagnon, Guillaume, et al.
Publicado: (2021)

Lung immunoglobulin A immunity dysregulation in cystic fibrosis
por: Collin, Amandine M., et al.
Publicado: (2020)

MicroRNA Expression in Cystic Fibrosis Airway Epithelium
por: Greene, Catherine M.
Publicado: (2013)

Aspergillus fumigatus in the cystic fibrosis lung: pros and cons of azole therapy
por: Burgel, Pierre-Régis, et al.
Publicado: (2016)

New Developments in Cystic Fibrosis Airway Inflammation
por: Palaniyar, Nades, et al.
Publicado: (2015)

Shifting Landscape of Airway Infection in Early Cystic Fibrosis
por: Hoppe, Jordana E., et al.
Publicado: (2019)

Infection and Inflammation MUC up the Cystic Fibrosis Airway
por: Ma, Jonathan
Publicado: (2022)

CFTR Modulators in People with Cystic Fibrosis: Real-World Evidence in France
por: Regard, Lucile, et al.
Publicado: (2022)

Transcriptional firing represses bactericidal activity in cystic fibrosis airway neutrophils
por: Margaroli, Camilla, et al.
Publicado: (2021)

Airway inflammatory markers in individuals with cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Bergin, David A, et al.
Publicado: (2013)

Immunomodulation in Cystic Fibrosis: Why and How?
por: Giacalone, Vincent D., et al.
Publicado: (2020)

Impact of COVID-19 on people with cystic fibrosis
por: Colombo, Carla, et al.
Publicado: (2020)

Airway Surface Liquid and Impaired Antiviral Defense in Cystic Fibrosis
por: Voynow, Judith A., et al.
Publicado: (2020)

Proline-Glycine-Proline (PGP) and High Mobility Group Box Protein-1 (HMGB1): Potential Mediators of Cystic Fibrosis Airway Inflammation
por: Gaggar, Amit, et al.
Publicado: (2010)

Major Decrease in Lung Transplantation for Patients with Cystic Fibrosis in France
por: Martin, Clémence, et al.
Publicado: (2021)

Immune Response in Cystic Fibrosis: Interplay between the Host and Microbes
por: Boutin, Sébastien, et al.
Publicado: (2023)

Letting It All Out: Neutrophils in Early Cystic Fibrosis Airway Inflammation
por: Perrem, Lucy, et al.
Publicado: (2019)

Dysfunctional Inflammation in Cystic Fibrosis Airways: From Mechanisms to Novel Therapeutic Approaches
por: Ghigo, Alessandra, et al.
Publicado: (2021)

Harnessing Neutrophil Survival Mechanisms during Chronic Infection by Pseudomonas aeruginosa: Novel Therapeutic Targets to Dampen Inflammation in Cystic Fibrosis
por: Marteyn, Benoît S., et al.
Publicado: (2017)

Effects of Lumacaftor-Ivacaftor on Airway Microbiota-Mycobiota and Inflammation in Patients with Cystic Fibrosis Appear To Be Linked to Pseudomonas aeruginosa Chronic Colonization
por: Enaud, Raphael, et al.
Publicado: (2023)

CFTR Modulator Therapies: Potential Impact on Airway Infections in Cystic Fibrosis
por: Saluzzo, Francesca, et al.
Publicado: (2022)

Shot Down Inflamed: Airway Smooth Muscle Bronchodilator Insensitivity in Cystic Fibrosis
por: Pascoe, Christopher D., et al.
Publicado: (2019)

Exacerbations of COPD
por: Pavord, Ian D, et al.
Publicado: (2016)

CT imaging shows specific pancreatic abnormalities in persons with cystic fibrosis related diabetes
por: Alexandre-Heymann, Laure, et al.
Publicado: (2023)

Abnormal pro-gly-pro pathway and airway neutrophilia in pediatric cystic fibrosis
por: Turnbull, Andrew R., et al.
Publicado: (2020)

“Can’t Stop the Feeling”: Symptoms as the Key to Trial Success in Bronchiectasis?
por: Burgel, Pierre-Régis, et al.
Publicado: (2020)

Pulmonary acceleration time to optimize the timing of lung transplant in cystic fibrosis
por: Damy, Thibaud, et al.
Publicado: (2012)

The fungal airway microbiome in cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Cuthbertson, Leah, et al.
Publicado: (2021)

Inhaled Dual Phosphodiesterase 3/4 Inhibitors for the Treatment of Patients with COPD: A Short Review
por: Martin, Clémence, et al.
Publicado: (2021)

Identification of Clinical Phenotypes Using Cluster Analyses in COPD Patients with Multiple Comorbidities
por: Burgel, Pierre-Régis, et al.
Publicado: (2014)

An attempt at modeling COPD epidemiological trends in France
por: Burgel, Pierre-Régis, et al.
Publicado: (2018)

The Ongoing Quest for Predictive Biomarkers in Chronic Obstructive Pulmonary Disease
por: Regard, Lucile, et al.
Publicado: (2023)

Clinical practice versus guidelines for the screening of cystic fibrosis-related diabetes: A French survey from the 47 centers
por: Weiss, Laurence, et al.
Publicado: (2022)

Charting a New Path: A Single-Cell Atlas of Porcine Cystic Fibrosis Airways at Birth
por: Britto, Clemente J.
Publicado: (2022)

Cystic fibrosis revisited
por: Kulkarni, H, et al.
Publicado: (2019)

Targeting miRNA-based medicines to cystic fibrosis airway epithelial cells using nanotechnology
por: McKiernan, Paul J, et al.
Publicado: (2013)

Early Antibiotics in Cystic Fibrosis: Lessons from the Cystic Fibrosis Pig Model
por: Lu, Shiping, et al.
Publicado: (2021)

Cystic Fibrosis Screen Positive, Inconclusive Diagnosis Genotypes in the Cystic Fibrosis Registry
por: Thompson, Cassandra, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lnosi6tpn0upno09nh4q60nm87